Shu Guang Chen

Shu Guang Chen

Auto-generated profile, based on publicly available information

Shu Guang Chen

Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, USA

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 1996 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
PPPiero Parchi
Piero Parchi
RCRudolph Castellani
Rudolph Castellani
SCSabina Capellari
Sabina Capellari
BGBernardino Ghetti
Bernardino Ghetti
KYKatherine Young
Katherine Young
PGPierluigi Gambetti
Pierluigi Gambetti

1 August 1995 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
SCShu G. Chen
Shu G. Chen
DTDavid B. Teplow
David B. Teplow
PPPiero Parchi
Piero Parchi
JTJan K. Teller
Jan K. Teller
PGPierluigi Gambetti
Pierluigi Gambetti
LALucila Autilio-Gambetti
Lucila Autilio-Gambetti
The cellular form of the prion protein (PrPc) is a glycoprotein anchored to the cell membrane by a glycosylphosphatidylinositol moiety. An aberrant form of PrPc that is partially resistant to proteases, PrP, is a hallmark of prion diseases, which in humans include Creutzfeldt-Jakob disease (CJD), Gerstmann-Sträussler-Scheinker syndrome, and fatal familial insomnia. We have characterized the major forms of PrP in normal and pathological human brains. A COOH-terminal fragment of PrPc, designated C1, is abundant in normal and CJD brains as well as in human neuroblastoma cells. Sequence analysis revealed that C1 contains alternative NH2 termini starting at His-111 or Met-112. Like PrPc, C1 is glycosylated, anchored to the cell membrane, and is heat-stable. Consistent with the lack of the NH2-terminal region of PrPc, C1 is more acidic than PrPc and does not bind heparin. An additional fragment longer than C1, designated C2, is present in substantial amounts in CJD brains. Like PrP, C2 is resistant to proteases and is detergent-insoluble. Our data indicate that C1 is a major product of normal PrPc metabolism, generated by a cleavage that disrupts the neurotoxic and amyloidogenic region of PrP comprising residues 106-126. This region remains intact in C2, suggesting a role for C2 in prion diseases.

1 June 2003 in British Medical Bulletin
Verified
Journal Article
Open access
PDF file
PGPierluigi Gambetti
Pierluigi Gambetti
QKQingzhong Kong
Qingzhong Kong
WZWenquan Zou
Wenquan Zou
PPPiero Parchi
Piero Parchi
SCShu G Chen
Shu G Chen
Prion diseases are unique transmissible neurodegenerative diseases that have diverse phenotypes and can be familial, sporadic, or acquired by infection. Recent findings indicate that the PrP genotype and the PrPSc type have a major influence on the disease phenotype in both sporadic and familial human prion diseases. This review attempts to classify and characterise sporadic and familial Creutzfeldt-Jakob disease (CJD) as a function of these two disease determinants. Based on the genotype at codon 129 on both PRNP alleles, the size of protease resistant PrPSc fragments and disease phenotype, we divide sporadic CJD into six subtypes: sCJDMM1/sCJDMV1, sCJDVV2, sCJDMV2, sCJDMM2, sCJDVV1, and sporadic fatal insomnia (sFI). Familial CJD is classified into many haplotypes based on the PRNP mutation and codon 129 (and other polymorphic codons) on the mutant allele. The clinical and pathological features are summarised for each sporadic CJD subtype and familial CJD haplotype.

6 October 2016 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SCShu G. Chen
Shu G. Chen
VSVilius Stribinskis
Vilius Stribinskis
MRMadhavi J. Rane
Madhavi J. Rane
DDDonald R. Demuth
Donald R. Demuth
EGEvelyne Gozal
Evelyne Gozal
RFrobert friedlandmd
robert friedlandmd
Misfolded alpha-synuclein (AS) and other neurodegenerative disorder proteins display prion-like transmission of protein aggregation. Factors responsible for the initiation of AS aggregation are unknown. To evaluate the role of amyloid proteins made by the microbiota we exposed aged rats and transgenicC.eleganstoE.coliproducing the extracellular bacterial amyloid protein curli. Rats exposed to curli-producing bacteria displayed increased neuronal AS deposition in both gut and brain and enhanced microgliosis and astrogliosis compared to rats exposed to either mutant bacteria unable to synthesize curli, or to vehicle alone. Animals exposed to curli producing bacteria also had more expression of TLR2, IL-6 and TNF in the brain than the other two groups. There were no differences among the rat groups in survival, body weight, inflammation in the mouth, retina, kidneys or gut epithelia, and circulating cytokine levels. AS-expressingC.elegansfed on curli-producing bacteria also had enhanced AS aggregation. These results suggest that bacterial amyloid functions as a trigger to initiate AS aggregation through cross-seeding and also primes responses of the innate immune system.

6 January 2012 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
XWXinglong Wang
Xinglong Wang
MYMichael H. Yan
Michael H. Yan
HFHisashi Fujioka
Hisashi Fujioka
JLJun Liu
Jun Liu
AWAmy Wilson-Delfosse
Amy Wilson-Delfosse
XZXiongwei Zhu
Xiongwei Zhu
The leucine-rich repeat kinase 2 (LRRK2) mutations are the most common cause of autosomal-dominant Parkinson disease (PD). Mitochondrial dysfunction represents a critical event in the pathogenesis of PD. We demonstrated that wild-type (WT) LRRK2 expression caused mitochondrial fragmentation along with increased mitochondrial dynamin-like protein (DLP1, also known as DRP1), a fission protein, which was further exacerbated by expression of PD-associated mutants (R1441C or G2019S) in both SH-SY5Y and differentiated primary cortical neurons. We also found that LRRK2 interacted with DLP1, and LRRK2–DLP1 interaction was enhanced by PD-associated mutations that probably results in increased mitochondrial DLP1 levels. Co-expression of dominant-negative DLP1 K38A or WT Mfn2 blocked LRRK2-induced mitochondrial fragmentation, mitochondrial dysfunction and neuronal toxicity. Importantly, mitochondrial fragmentation and dysfunction were not observed in cells expressing either GTP-binding deficient mutant LRRK2 K1347A or kinase-dead mutant D1994A which has minimal interaction with DLP1 and did not increase the mitochondrial DLP1 level. We concluded that LRRK2 regulates mitochondrial dynamics by increasing mitochondrial DLP1 through its direct interaction with DLP1, and LRRK2 kinase activity plays a critical role in this process.

20 December 2003 in Biochemistry
Verified
Journal Article
Closed access
CACraig S Atwood
Craig S Atwood
George PerryGeorge Perry
George Perry
HZHong Zeng
Hong Zeng
YKYoji Kato
Yoji Kato
WJWalton D. Jones
Walton D. Jones
Ashley I. BushAshley I. Bush
Ashley I. Bush